DK0671414T3 - Dermatansulfatsammensætning som antitrombotisk middel - Google Patents
Dermatansulfatsammensætning som antitrombotisk middelInfo
- Publication number
- DK0671414T3 DK0671414T3 DK94927827T DK94927827T DK0671414T3 DK 0671414 T3 DK0671414 T3 DK 0671414T3 DK 94927827 T DK94927827 T DK 94927827T DK 94927827 T DK94927827 T DK 94927827T DK 0671414 T3 DK0671414 T3 DK 0671414T3
- Authority
- DK
- Denmark
- Prior art keywords
- antithrombotic agent
- agents
- sulfate composition
- combined
- dermatane sulfate
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/49—Urokinase; Tissue plasminogen activator
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
- C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
- C08B37/0069—Chondroitin-4-sulfate, i.e. chondroitin sulfate A; Dermatan sulfate, i.e. chondroitin sulfate B or beta-heparin; Chondroitin-6-sulfate, i.e. chondroitin sulfate C; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L5/00—Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L5/00—Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
- C08L5/08—Chitin; Chondroitin sulfate; Hyaluronic acid; Derivatives thereof
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Dermatology (AREA)
- Polymers & Plastics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Materials Engineering (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Diabetes (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Materials For Medical Uses (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Medicines Containing Plant Substances (AREA)
- Compounds Of Unknown Constitution (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP26975893 | 1993-09-30 | ||
PCT/JP1994/001643 WO1995009188A1 (fr) | 1993-09-30 | 1994-09-30 | Antithrombotique |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0671414T3 true DK0671414T3 (da) | 2002-04-22 |
Family
ID=17476745
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK94927827T DK0671414T3 (da) | 1993-09-30 | 1994-09-30 | Dermatansulfatsammensætning som antitrombotisk middel |
Country Status (17)
Country | Link |
---|---|
US (1) | US5801162A (da) |
EP (2) | EP1125977A1 (da) |
JP (1) | JP3813169B2 (da) |
KR (1) | KR950704362A (da) |
CN (1) | CN1115182A (da) |
AT (1) | ATE211487T1 (da) |
CA (1) | CA2150552C (da) |
DE (1) | DE69429576T2 (da) |
DK (1) | DK0671414T3 (da) |
ES (1) | ES2173124T3 (da) |
FI (1) | FI952593A (da) |
HU (1) | HU219339B (da) |
NO (1) | NO308856B1 (da) |
PL (2) | PL177245B1 (da) |
RU (1) | RU2153506C2 (da) |
SG (1) | SG67928A1 (da) |
WO (1) | WO1995009188A1 (da) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1274351B (it) * | 1994-10-06 | 1997-07-17 | Alfa Wassermann Spa | Uso di alcuni glicosaminoglicani nella dialisi peritoneale. |
JP4027973B2 (ja) * | 1995-09-19 | 2007-12-26 | 生化学工業株式会社 | 抗炎症剤 |
US6413931B1 (en) | 1999-05-10 | 2002-07-02 | The Texas A&M University System | Peptide inhibitor of fibrinogen blood clotting |
JP2001187740A (ja) * | 2000-01-05 | 2001-07-10 | Seikagaku Kogyo Co Ltd | 創傷治療剤 |
JP2001151680A (ja) * | 1999-11-24 | 2001-06-05 | Seikagaku Kogyo Co Ltd | 鎮痒剤 |
JP4633232B2 (ja) * | 2000-06-22 | 2011-02-16 | 生化学工業株式会社 | 成長因子誘導剤 |
JP2002080371A (ja) * | 2000-06-23 | 2002-03-19 | Seikagaku Kogyo Co Ltd | プラスミノーゲンアクチベーター活性促進剤 |
WO2003102160A2 (en) | 2002-06-03 | 2003-12-11 | Massachusetts Institute Of Technology | Rationally designed polysaccharide lyases derived from chondroitinase b |
CN100384884C (zh) * | 2006-05-29 | 2008-04-30 | 南京健友生物化学制药有限公司 | 肝素钠副产物中分离提纯硫酸皮肤素和低分子硫酸乙酰肝素的方法 |
JP4524296B2 (ja) * | 2007-03-30 | 2010-08-11 | 生化学工業株式会社 | 発毛促進剤 |
JP4881246B2 (ja) * | 2007-07-13 | 2012-02-22 | 生化学工業株式会社 | 発毛効果増強剤 |
IT1401253B1 (it) | 2010-04-23 | 2013-07-18 | Uni Degli Studi Carlo Bo Urbino | Uso del sulodexide per la riduzione delle metalloproteinasi di matrice. |
WO2013006906A1 (en) * | 2011-07-11 | 2013-01-17 | Commonwealth Scientific And Industrial Research Organisation | Dermatan sulphate, pharmaceutical compositions and process for producing same |
CN109596742B (zh) * | 2018-12-25 | 2022-04-26 | 深圳市格利科生物科技有限公司 | 一种检测硫酸乙酰肝素成品中主要成分含量的方法 |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2535324A1 (fr) * | 1982-10-27 | 1984-05-04 | Choay Sa | Station perfectionnee pour l'epuration d'eaux usees |
EP0112122B1 (en) * | 1982-12-14 | 1991-08-28 | South African Inventions Development Corporation | Plasminogen activator |
JPS59138202A (ja) * | 1983-01-27 | 1984-08-08 | Rikagaku Kenkyusho | 新規な硫酸化アミノ糖含有多糖及びその製造法 |
IT1208509B (it) * | 1985-03-13 | 1989-07-10 | Mediolanum Farmaceutici Srl | Processo per la produzione di eparan solfato e dermatan solfato naturali sostanzialmente puri eloro impiego farmaceutico. |
DE3512909A1 (de) * | 1985-04-11 | 1986-10-23 | Behringwerke Ag, 3550 Marburg | Verfahren zur bestimmung von plasminogenaktivatoren (pa) |
IT1214609B (it) * | 1985-05-17 | 1990-01-18 | Opocrin Spa | Esosaminoglicani solfati depolimerizzati ad attivita'antitrombotica, fibrinolitica, antinfiammatoria, loro procedimento di preparazione e composizioni farmaceutiche che li contengono. |
FR2584728B1 (fr) * | 1985-07-12 | 1987-11-20 | Choay Sa | Procede de sulfatation de glycosaminoglycanes et de leurs fragments |
IT1189085B (it) * | 1986-03-25 | 1988-01-28 | Mediolanum Farmaceutici Srl | Processo per la preparazione di dermatan solfato ad alta purezza e composizioni farmaceutiche che lo contengono |
JPH069042B2 (ja) * | 1986-09-10 | 1994-02-02 | 日本電気株式会社 | 共用記憶媒体の順次アクセス制御装置 |
JP2667469B2 (ja) * | 1988-10-06 | 1997-10-27 | 日本放送協会 | 撮像管用偏向ヨーク |
EP0421508B1 (en) * | 1989-10-04 | 1993-12-15 | Akzo Nobel N.V. | Sulphated glycosaminoglycuronan with antithrombotic activity |
US5118793A (en) * | 1989-10-20 | 1992-06-02 | Washington University | Modified heparin cofactor II |
US5382570A (en) * | 1990-04-23 | 1995-01-17 | Akzo, N.V. | Sulfated glycosaminoglycanoid derivatives of the dermatan sulfate and chondroitin sulfate type |
FR2663639B1 (fr) * | 1990-06-26 | 1994-03-18 | Rhone Poulenc Sante | Melanges de polysaccharides de bas poids moleculaires procede de preparation et utilisation. |
CA2070813C (en) * | 1990-11-05 | 1996-10-29 | Hendrik Coenraad Hemker | A method to determine the concentration of anticoagulants |
IT1245761B (it) * | 1991-01-30 | 1994-10-14 | Alfa Wassermann Spa | Formulazioni farmaceutiche contenenti glicosaminoglicani assorbibili per via orale. |
IT1251183B (it) * | 1991-08-28 | 1995-05-04 | Opocrin Spa | Dermatan solfato ad alto titolo, dotato di elevata attivita' trombolitica, e forme farmaceutiche che lo contengono. |
-
1994
- 1994-09-30 PL PL94328012A patent/PL177245B1/pl unknown
- 1994-09-30 EP EP01201321A patent/EP1125977A1/en not_active Withdrawn
- 1994-09-30 CA CA002150552A patent/CA2150552C/en not_active Expired - Fee Related
- 1994-09-30 CN CN94190743A patent/CN1115182A/zh active Pending
- 1994-09-30 DK DK94927827T patent/DK0671414T3/da active
- 1994-09-30 EP EP94927827A patent/EP0671414B1/en not_active Expired - Lifetime
- 1994-09-30 ES ES94927827T patent/ES2173124T3/es not_active Expired - Lifetime
- 1994-09-30 WO PCT/JP1994/001643 patent/WO1995009188A1/ja active IP Right Grant
- 1994-09-30 PL PL94309218A patent/PL177218B1/pl unknown
- 1994-09-30 KR KR1019950702147A patent/KR950704362A/ko not_active Application Discontinuation
- 1994-09-30 US US08/446,662 patent/US5801162A/en not_active Expired - Lifetime
- 1994-09-30 DE DE69429576T patent/DE69429576T2/de not_active Expired - Lifetime
- 1994-09-30 HU HU9501542A patent/HU219339B/hu not_active IP Right Cessation
- 1994-09-30 AT AT94927827T patent/ATE211487T1/de not_active IP Right Cessation
- 1994-09-30 JP JP51022895A patent/JP3813169B2/ja not_active Expired - Fee Related
- 1994-09-30 RU RU95112534/04A patent/RU2153506C2/ru not_active IP Right Cessation
- 1994-09-30 SG SG1996008133A patent/SG67928A1/en unknown
-
1995
- 1995-05-29 FI FI952593A patent/FI952593A/fi unknown
- 1995-05-30 NO NO952137A patent/NO308856B1/no not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
SG67928A1 (en) | 1999-10-19 |
NO952137D0 (no) | 1995-05-30 |
CA2150552C (en) | 1999-12-21 |
ATE211487T1 (de) | 2002-01-15 |
FI952593A0 (fi) | 1995-05-29 |
AU7708594A (en) | 1995-04-18 |
RU95112534A (ru) | 1997-03-20 |
DE69429576T2 (de) | 2002-08-22 |
KR950704362A (ko) | 1995-11-20 |
EP0671414A1 (en) | 1995-09-13 |
HUT73245A (en) | 1996-07-29 |
HU9501542D0 (en) | 1995-07-28 |
JP3813169B2 (ja) | 2006-08-23 |
PL177245B1 (pl) | 1999-10-29 |
CN1115182A (zh) | 1996-01-17 |
PL309218A1 (en) | 1995-10-02 |
PL177218B1 (pl) | 1999-10-29 |
FI952593A (fi) | 1995-07-28 |
EP0671414B1 (en) | 2002-01-02 |
HU219339B (en) | 2001-03-28 |
AU699371B2 (en) | 1998-12-03 |
NO308856B1 (no) | 2000-11-06 |
EP1125977A1 (en) | 2001-08-22 |
RU2153506C2 (ru) | 2000-07-27 |
ES2173124T3 (es) | 2002-10-16 |
DE69429576D1 (de) | 2002-02-07 |
WO1995009188A1 (fr) | 1995-04-06 |
NO952137L (no) | 1995-07-26 |
EP0671414A4 (en) | 1995-11-15 |
US5801162A (en) | 1998-09-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK0671414T3 (da) | Dermatansulfatsammensætning som antitrombotisk middel | |
BR9811825A (pt) | Uso de lactobacillus para redução do nìvel de fibrinogênio no sangue | |
SE8903914D0 (sv) | Oral composition for the treatment of inflammatory bowel diseases | |
SE9404196D0 (sv) | New antithrombotic formulation | |
KR970704429A (ko) | 심혈관 질환의 치료를 위한 드롤록시펜의 용도(use of droloxifene for the treatment of cardiovascular diseases) | |
MXPA03010085A (es) | Composiciones y su uso en la hiperplasia. | |
EA199900499A1 (ru) | Фармацевтическая композиция, включающая соединение, обладающее анти-xa активностью, и соединение антагонист агрегации тромбоцитов | |
DE69116380D1 (de) | Pharmazeutische zubereitung zur behandlung verlängerter gerinnungszeit | |
Chen et al. | Can tranexamic acid and hydrogen peroxide reduce blood loss in cemented total knee arthroplasty? | |
Levy | Hemostatic agents. | |
ATE201823T1 (de) | Topische pharmazeutische zusammensetzungen, welche heparin enthalten | |
CA2033249A1 (en) | Cytostatic or cytotoxic combination of active substances for use in therapeutic procedures | |
CO5280202A1 (es) | Metodos de tratamiento y metodos de rastreo de farmacos | |
Bartkowski et al. | Combined treatment with antibiotic, heparin and streptokinase—a new approach to the therapy of bacterial osteomyelitis | |
EP1222854A4 (en) | PREVENTION AND TREATMENT OF DISEASES ASSOCIATED WITH BLOOD COAGULATION | |
Francis et al. | Thrombin activity associated with indwelling central venous catheters | |
Khatri et al. | Spontaneous arterial thrombosis associated with nephrotic syndrome: case report and review of the literature | |
NO961046L (no) | Fremgangsmåte for behandling av pasienter med akutt hjerteinfarkt som ikke gjennomgår trombolytisk behandling med hirudin og acetylsalicylsyre | |
PT711163E (pt) | Utilizacao de benzidamina no tratamento de estados patologicos provocados por tnf | |
Loeliger | Does dipyridamole have antithrombotic potential? | |
MX9304601A (es) | Composicion antimicrobiana, analgesica, antinflamatoria, que favorece lacicatrizacion de heridas, quemaduras y ulceras dermicas. | |
RU95116161A (ru) | Способ лечения синдрома диссеминированного внутрисосудистого микротромбоза при тяжелой изолированной и сочетанной черепно-мозговой травме | |
RU96122234A (ru) | Способ воздействия на печеночный кровоток у больных с гепатобилиарной патологией |